Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention American Medical Association (AMA), the most common co-covered peer. Office of Prescription Drug Promotion (OPDP) appears in 1 tracked Biotech story from March 9, 2026.
Last mentioned: Mar 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention American Medical Association (AMA), the most common co-covered peer. Office of Prescription Drug Promotion (OPDP) appears in 1 tracked Biotech story from March 9, 2026. The tracked stories average 3 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Office of Prescription Drug Promotion (OPDP). Shared-story counts are live from our verified record — not editorial picks.
The pharmaceutical industry faces renewed scrutiny over direct-to-consumer (DTC) advertising, a practice unique to the U.S. and New Zealand. As healthcare costs rise, regulators are weighing the educational benefits of these ads against their role in driving up prescription volumes and drug prices.
Office of Prescription Drug Promotion (OPDP) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
